Physician profile
Terry J True
NPI 1467468454
$2,401.47
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $738 · 2021: $827 · 2022: $413.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $570.66 | 2019-2022 | |
| Glaxosmithkline, LLC. | $322.79 | 2019-2022 | |
| Lilly USA, LLC | $291.71 | 2020-2022 | |
| Pfizer INC. | $220.46 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.10 | 2019-2021 | |
| Amgen INC. | $133.64 | 2019-2021 | |
| Abbvie INC. | $98.21 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $91.33 | 2019-2020 | |
| Bausch Health US, LLC | $87.46 | 2019-2022 | |
| Amarin Pharma, INC. | $86.06 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $55.54 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $53.78 | 2020 | |
| Astellas Pharma US INC | $46.35 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.34 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $37.32 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $25.65 | 2021 | |
| Horizon Therapeutics Plc | $15.61 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.23 | 2021 | |
| Ironwood Pharmaceuticals, INC | $13.23 | 2020 | |
| Allergan, INC. | $12.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry True listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.